Erythropoietin Injection IP

Name: Erythropoietin Injection IP
Brand: MEDICINE PLANET

Get a Price/Quote

MOQ : 5 Boxes

Erythropoietin Injection IP Specification

Life Span
Refer to expiry date on package

Packaging Type
Pre-filled syringe (PFS)

Indication
Anemia associated with chronic kidney disease, anemia due to chemotherapy

Brand Name
La Renon

Dosage Form
Injection

Salt Composition
Erythropoietin Alfa

Origin of Medicine
India

Pacakaging (Quantity Per Box)
Pack of 1 pre-filled syringe (PFS)

Drug Type
Biological

Ingredients
Recombinant Human Erythropoietin Alfa

Physical Form
Injection

Function
Stimulates erythropoiesis (red blood cell production)

Recommended For
Patients with anemia, especially due to chronic kidney disease or chemotherapy

Dosage
As directed by the physician

Dosage Guidelines
Administer subcutaneously or intravenously as instructed by healthcare provider

Suitable For
Adults and pediatric patients as prescribed

Quantity
4000 IU/0.4 ml

Storage Instructions
Store at 2C to 8C. Do not freeze.

Therapeutic Class
Hematopoietic agent

Appearance
Clear, colorless solution

Prescription Required
Yes

Regulatory Approval
As per Indian regulatory standards

Route of Administration
Subcutaneous or Intravenous

Volume Per Syringe
0.4 ml

Strength
4000 IU

Erythropoietin Injection IP Trade Information

Minimum Order Quantity
5 Boxes

Payment Terms
Cash in Advance (CID)

Supply Ability
100 Boxes Per Month

Delivery Time
7 Days

Main Domestic Market
All India

About Erythropoietin Injection IP

La Renon's Erythropoietin Injection IP, a best-seller in the hematopoietic agent category, is a classic solution for procuring optimal health in patients battling anemia, particularly when caused by chronic kidney disease or chemotherapy. This inestimable, pivotal injection contains 4000 IU of Recombinant Human Erythropoietin Alfa in each 0.4 ml pre-filled syringe, ensuring accurate dosing. Manufactured in India in accordance with stringent regulatory standards, its clear, colorless solution is suitable for both adults and pediatric patients. Prescription is required.

Comprehensive Suitability and Purpose of Erythropoietin Injection IP

Erythropoietin Injection IP is suitable for both adults and pediatric patients as prescribed by a physician. It is uniquely recommended for use in individuals with anemia, particularly due to chronic kidney disease or as a result of chemotherapy. The medication is administered either subcutaneously or intravenously and functions by stimulating the production of red blood cells, effectively countering anemia and its associated complications under guided medical supervision.

Swift Delivery, Secure Packaging, and International Reach

La Renon utilizes robust goods transport networks to handover Erythropoietin Injection IP to clients with minimized timelines. Each pack contains 1 pre-filled syringe and is expertly packaged to maintain the lowest price without compromising quality or safety. The product is mainly exported to major international markets with compliance to regulatory standards, ensuring goods reach their destination promptly and in optimal condition.

FAQ's of Erythropoietin Injection IP:

Q: How should Erythropoietin Injection IP be stored to maintain its efficacy?

A: Erythropoietin Injection IP should be stored between 2C and 8C. It must not be frozen, and should be kept in its original packaging until use to preserve its quality.

Q: What is the recommended process for administering Erythropoietin Injection IP?

A: This injection is administered either subcutaneously or intravenously as instructed by your healthcare provider. Dosage and frequency depend on individual medical needs and should always follow a physician's direction.

Q: When is Erythropoietin Injection IP indicated for use?

A: It is indicated for the treatment of anemia associated with chronic kidney disease or anemia resulting from chemotherapy. Always consult your healthcare provider to determine if it is appropriate for your condition.

Q: Where is Erythropoietin Injection IP manufactured and exported from?

A: Erythropoietin Injection IP is manufactured by La Renon in India and is exported globally to markets adhering to strict quality standards.

Q: What are the pivotal benefits of using Erythropoietin Injection IP?

A: The injection effectively stimulates red blood cell production, helping to alleviate symptoms of anemia and improve quality of life for those with chronic kidney disease or undergoing chemotherapy.

Q: Is Erythropoietin Injection IP suitable for children as well as adults?

A: Yes, this medication can be used for both adults and pediatric patients, but only under the supervision and prescription of a qualified healthcare provider.